Product

CYP17 Lyase Inhibitor

Name: CYP17 Lyase Inhibitor
Brand: Innocrin Pharmaceuticals, Inc.

PHARMACEUTICAL

United States (US)

ABOUT THE PRODUCT

A novel, oral CYP17 lyase inhibitor under development for the treatment of castration-resistant prostate cancer.

Information is owner-confirmed

Last updated 1 month ago

Price range

N/A